Metabolic
HTA: concept to reality Co-chair
by: J.-C. Fruchart
(France)
Title
to be advised ................................................................................................................................
P. Valensi (France)
Title
to be advised .................................................................................................................................
B. Vaisse (France)
02.00
p.m. – 03.30 p.m.
ACADEMIC
SESSION 2
New
perspectives for HDL-targeted therapies Co-chair
by: C. Calvo (Chile) & R.
Ceska (Czek Republic)
Pleiotropic
functions of HDL .........................................................................................
A. Von Eckardstein (Switzerland)
New
pathways of cellular cholesterol
efflux ................................................................................................
A. Tall (USA)
HDL:
a new target for the treatment
of the metabolic syndrome and
atherosclerosis ...........................
B. Brewer (USA)
Title
to be advised ...................................................................................................................
S. Santa-Marina Fojo (USA)